FEATURES OF PREGNANCY MANAGEMENT AND SCREENING OF HYPERGLYCEMIA IN PREGNANT WOMEN DURING PANDEMIC COVID-19

Khanyukov O. O., Sapozhnychenko L. V., Getman M. G., Ivchyna N. A., Bulba P. A.

LITERATURE REVIEWS

Scentific article

Abstract. Background. Due to the fact that the COVID-19 pandemic has affected all areas of medicine, including the provision of care to pregnant women, it is important for doctors to know exactly how the guidelines for pregnancy have changed during this period, and to pay special attention to the problem of timely treatment, diagnosis and treatment of diabetes mellitus in pregnant women as this concomitant pathology has a significant negative prognostic effect on the cause of COVID-19 for mother and fetus. Aim. Review literature illustrating current data about features of pregnancy management and screening of hyperglycemia in pregnant women during pandemic COVID-19. Methods. This work presents review of literature about features of pregnancy management and screening of hyperglycemia in pregnant women during pandemic COVID-19, based on a search of English-language articles in the PubMed database and the temporary guidelines “Prevention, diagnosis and treatment of new coronavirus infection (COVID-19)” Version 10 (08.02.2021), approved by the Ministry of Health of Russia. Results. In a pandemic of acute respiratory syndrome caused by COVID-19 virus, there is a classification of clinical cases recommended by the the WHO’s interim guidance, “Global surveillance for COVID‐19 caused by human infection with COVID‐19 virus”, namely a suspected probable and confirmed cases that can be used by medical professionals to prevent contact between patients at different stages of diagnosis. Suspected and probable cases are recommended to be observed in the isolation room, and confirmed – to be placed in the isolation room with negative pressure. General treatment includes maintenance of fluid, electrolyte balance and symptomatic therapy. Oxygen therapy is mandatory. In all cases, the analysis of vital indicators of the mother’s body and cardiotocography (CTG) of the fatal heart rate during pregnancy 23-28 weeks. To reduce contact between patients, the number of visits to the clinic by women at low risk of complications during pregnancy is recommended to be reduced and replaced by virtual counseling. In cases of a positive COVID-19 screening result, a visit to the clinic should be postponed for 14 days if the visit is not urgent for the mother and / or fetus, in which case doctors should be consulted using appropriate personal protective equipment. Childbirth is recommended through the natural birth canal. The reason for emergency cesarean section is septic shock, acute organ failure or fetal distress. The child and the mother are separated only if the mother’s condition is considered serious. Patronage of the child after birth can be carried out remotely in the absence of the need for a visit to a specialist. In terms of screening for hyperglycemia in pregnant women during the COVID-19 pandemic, it is recommended to use alternative strategies using the determination of glycosylated hemoglobin, random (non-fasting) measurement of plasma glucose and fasting plasma, which are performed during routine antenatal studies on 12 and 28 weeks to detect diabetes mellitus. In a pandemic, telemedicine, a service provided by healthcare professionals using remote communication technologies, has become important. Conclusions. Current knowledge will help improve existing approaches to care for pregnant women, reduce the likelihood of pregnancy complications, and improve the diagnosis and control of gestational diabetes during the COVID-19 pandemic

acute respiratory syndrome, pregnancy, COVID-19, diabetes mellitus.

1. Shek CC, Ng PC, Fung GPG, Cheng FWT, Chan PKS, Peiris MJS, et al. Infants born to mothers with severe acute respiratory syndrome. Pediatrics. 2003;112(4):254–6.
2.  Alfaraj SH, Al-Tawfiq JA, Memish ZA. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection during pregnancy: Report of two cases & review of the literature. J Microbiol Immunol Infect. 2019;52(3):501–3.
3. Allotey J, Stallings E, Bonet M, Yap M, Chatterjee S, Kew T, et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: Living systematic review and meta-analysis. BMJ. 2020;370:m3320.
4.  Zhu H, Wang L, Fang C, Peng S, Zhang L, Chang G, et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr. 2020;9(1):51–60.
5. Liu Y, Chen H, Tang K, Guo Y. Clinical manifestations and outcome of SARS-CoV-2 infection during pregnancy. J of Infect 2020;2020:30109-2.
6. Shaw GM, Todoroff K, Velie EM, Lammer EJ. Maternal illness, including fever, and medication use as risk factors for neural tube defects. Teratology. 1998;57(1):1–7.
7. Oster ME, Riehle-Colarusso T, Alverson CJ, Correa A. Associations between maternal fever and influenza and congenital heart defects. J Pediatr. 2011;158(6):990–5. DOI: http://dx.doi.org/10.1016/j.jpeds.2010. 11.058
8. Abe K, Honein MA, Moore CA. Maternal Febrile Illnesses, Medication Use, and the Risk of Congenital Renal Anomalies. Birth Defects Res Part A – Clin Mol Teratol. 2003;67(11):911–8.
9. Sass L, Urhoj SK, Kjærgaard J, Dreier JW, Strandberg-Larsen K, Nybo Andersen AM. Fever in pregnancy and the risk of congenital malformations: A cohort study. BMC Pregnancy Childbirth. 2017;17(1):1–9.
10. Madinger NE, Greenspoon JS, Ellrodt AG. Pneumonia during pregnancy: Has modern technology improved maternal and fetal outcome? Am J Obstet Gynecol [Internet]. 1989;161(3):657–62. Available from: http://dx. doi.org/10.1016/0002-9378(89)90373-6
11. Schwartz DA. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: Maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med. 2020;144(7):799–805.
12. Zakony, kodeksy i normativno-pravovyye akty Rossiyskoy Federatsii. Vremennyye metodicheskiye rekomendatsii “Profilaktika, diagnostika i lecheniye novoy koronavirusnoy infektsii (COVID-19)” versiya 10 [Internet]; 2021 Fevr 08. Dostupno: https://legalacts.ru/doc/vremennyemetodicheskie-rekomendatsii-profilaktika-diagnostika-i-lechenie-novoi-koronavirusnoi_8/. [in Russian].
13. World Health Organization (WHO). Global Surveillance for COVID-19 caused by human infection with COVID-19 virus: interim guidance. [Internet]. WHO; 2020. Available from: https://www.who.int/publications-detail/global-surveillance-for-human-infection-with-novelcoronavirus-(2019-ncov)
14. Poon LC, Yang H, Kapur A, Melamed N, Dao B, Divakar H, et al. Global interim guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium from FIGO and allied partners: Information for healthcare professionals. Int J Gynecol Obstet. 2020;149(3):273–86.
15. Li B, Yang J, Zhao F, Zhi L, Wang X, Liu L, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531–8.
16. Zhao W, Zhong Z, Xie X, Yu Q, Liu J. Relation between chest CT findings and clinical conditions of coronavirus disease (covid-19) pneumonia: A multicenter study. Am J Roentgenol. 2020;214(5):1072–7.
17. Maxwell C, McGeer A, Tai KFY, Sermer M. Management Guidelines for Obstetric Patients and Neonates Born to Mothers With Suspected or Probable Severe Acute Respiratory Syndrome (SARS ). J Obstet Gynaecol Can. 2009;31(4):358-364.
18. NIH. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Nih. 2020;2019:130. Availanle from: https://covid19treatmentguidelines. nih. gov/.
19. Metlay JP, Waterer GW, Long AC, Anzueto A, Brozek J, Crothers K, et al. Diagnosis and treatment of adults with community-acquired pneumonia. Am J Respir Crit Care Med. 2019;200(7):45–67.
20. Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ. Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know. 2020;(January). Am J Obstet Gynecol. 2020;222(5):415-426.
21. Lansbury LE, Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS. Corticosteroids as adjunctive therapy in the treatment of influenza: An updated cochrane systematic review and meta-analysis. Crit Care Med. 2020;(3):98–106.
22. Boelig RC, Saccone G, Bellussi F, Berghella V. MFM guidance for COVID-19. Am J Obstet Gynecol MFM. 2020;2(2):100-106.
23. Mullins E, Evans D, Viner RM, O’Brien P, Morris E. Coronavirus in pregnancy and delivery: rapid review. Ultrasound Obstet Gynecol. 2020;55(5):586–92.
24. Hussain A, Bhowmik B, Cristina N. COVID-19 and diabetes: Knowledge in progress. Diabetes Res Clin Pract. 2020 Apr;162:108142.
25. Paranjpe I, Russak AJ, De Freitas JK, Lala A, Miotto R, Vaid A, et al. Retrospective cohort study of clinical characteristics of 2199 hospitalised patients with COVID-19 in New York City. BMJ Open. 2020;10(11):1–11.
26. Roncon L, Zuin M, Rigatelli G, Zuliani G. Los pacientes diabéticos con infección por COVID-19 tienen un mayor riesgo de ingreso en la UCI y un mal pronóstico a corto plazo. Lo que todo medico debe saber. 2020;7:1-8.
27. Puig-Domingo M, Marazuela M, Giustina A. COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology. Endocrine. 2020;68(1):2–5. DOI: http://dx.doi.org/10.1007/s12020-020-02294-5
28. Banerjee M, Chakraborty S, Pal R. Diabetes self-management amid COVID-19 pandemic2020;(January).
29. Meek CL, Lindsay RS, Scott EM, Aiken CE, Myers J, Reynolds R, et al. Approaches to screening for hyperglycaemia in pregnant women during and after the COVID-19 pandemic. Diabetic Medicine. 2021;38(1):e14380
30. Nouhjah S, Jahanfar S, Shahbazian H. Temporary changes in clinical guidelines of gestational diabetes screening and management during COVID-19 outbreak: A narrative review. Diabetes Metab Syndr. 2020;14(5):939–942.
31. Albert L, Capel I, García-Sáez G, Martín-Redondo P, Hernando ME, Rigla M. Managing gestational diabetes mellitus using a smartphone application with artificial intelligence (SineDie) during the COVID-19 pandemic: Much more than just telemedicine. Diabetes Res Clin Pract. 2020 Nov;169:108396.
32. Xie W, Dai P, Qin Y, Wu M, Yang B, Yu X. Effectiveness of telemedicine for pregnant women with gestational diabetes mellitus: An updated meta-analysis of 32 randomized controlled trials with trial sequential analysis. BMC Pregnancy Childbirth. 2020;20(1):1–14.

«Bulletin of problems biology and medicine» Issue 2 (160), 2021 year, 55-63 pages, index UDK 618.3-07:616.153.455-008.61:616.98:578.834COVID-19-036.21:004

10.29254/2077-4214-2021-2-160-55-63